FDCC
TDOC icon

Foster Dykema Cabot & Co’s Teladoc Health TDOC Stock Holding History

Foster Dykema Cabot & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1K Hold
46
– – ﹤0.01% 320
2023
Q2 		$1K Hold
46
– – ﹤0.01% 379
2023
Q1 		$1K Buy
+46
New +$1.23K ﹤0.01% 236

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Foster Dykema Cabot & Co's TDOC Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Teladoc Health (TDOC) position steady in Q3 2023 at 46 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #320.

Foster Dykema Cabot & Co first reported a position in TDOC in Q1 2023 and has held it in 3 quarters since. 436 funds tracked by Wall St. Rank hold TDOC as of Q3 2023.

  • Foster Dykema Cabot & Co held 46 shares of Teladoc Health worth $1K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Teladoc Health share count unchanged in Q3 2023.
  • Teladoc Health made up ﹤0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #320 holding.
  • Foster Dykema Cabot & Co first reported a position in Teladoc Health in Q1 2023 and has held it in 3 quarters since.
  • 436 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.